Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DRP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ACAN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GYPA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CPXM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TERT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC82 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
NFATC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAGI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FZR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANTXR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LTBR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF395 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C5orf42 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZBTB46-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on